1Holig P, Bach M, Volkel T, et al. Novel RGD lipopeptides for the targeting of lipesomes to integrin-expressing endothelial and melanoma cells. Protein Eng Des Sel, 2004, 17: 433-441.
2Takagi J. Structural basis for ligand recognition by RGD (Arg-Gly-Asp ) -dependent integrins. Biochem Soc Trans, 2004, 32: 403-406.
3Assa-Munt N, Jia X, Laakkonen P, et al. Solution structures and integrin binding activities of an RGD peptide with two isomers. Biochemistry, 2001,40: 2373-2378.
5Haubner R, Bruchertseifer F, Bock M, et al. Synthesis and biological evaluation of a 99Tcm-labeled cyclic RGD peptide for imaging the cry 133 expression. Nuklearmedizin, 2004, 43 : 26-32.
6Assa-Munt N, Jia X, Laakkonen P, et al. Solution structures and intergrin binding activities of an RGD peptide with two isomers. Biochemistry, 2001, 40: 2373-2378.
7Max R, Gerritsen RR, Nooijen PT, et al. Immunohistochemical analysis of integrin alpha v beta 3 expression on tumor-associated vessels of human carcinomas. Int J Cancer, 1997, 71 : 320-324.
